Q4 Inc. Acquires Virtua Research to Bring AI-Powered Consensus Management to IR Operations April 14, 2026 Acquisition adds analyst consensus data to Q4 platform—with Q4’s AI applied to help IR teams identify shifts and proactively manage market expectations
Cloudflare Partners with Wiz to Secure the Global AI Attack Surface, Eliminating Blind Spots Caused by Shadow AI April 14, 2026 New integration gives organizations a clear path from identifying AI risks to stopping attacks in real time
Cloudflare Launches Mesh to Secure the AI Agent Lifecycle April 14, 2026 Cloudflare Mesh helps any developer encrypt every human, code, and agent connection point without ever exposing internal infrastructure and data to the public Internet
Acumetis Launches as a Single Integrated Brand to Transform Life Sciences Commercialization April 14, 2026 Leading Pharmaceutical and Biotech Consultancies Combine to Create a Full-Service Commercialization Powerhouse Five leading life sciences organizations - Herspiegel, Adivo Associates, Decisive Consulting, Fiecon, and Sixsense Strategy Group - have come together as a single integrated brand to support better decision-making across the entire biopharma product lifecycle. The landmark move is inspired by the need to provide a new level of counsel and enhanced strategic clarity to clients operating in an age of complexity and rapid evolution. The combined businesses bring together more than 350 experts across the United States, Canada, UK, Europe, South America and Asia and covers Commercial Strategy, Launch Excellence, Patient Access and Support, Value and Access, Insights and Analytics, and Medical Affairs. This new brand and integrated commercial model mark a strategic milestone for Acumetis, launching 14 April 2026.
ZincFive Surpasses 2 GW Milestone Underscoring Commercial Adoption of Nickel-Zinc in Data Centers April 14, 2026 ZincFive®, the world leader in nickel-zinc (NiZn) battery-based solutions for immediate power applications, has surpassed 2 gigawatts (GW) in power delivered or contracted globally, reinforcing the growing adoption of nickel-zinc as a preferred alternative to legacy battery technologies in data center infrastructure. This milestone reflects accelerating customer demand for solutions that deliver high power density, [...]
Expedia Group Reveals ‘The AI Trust Gap’: Travelers Embrace AI for Planning but Rely on Trusted Brands to Book April 14, 2026 New report finds nearly 70% of travelers prefer booking with trusted travel brands over AI chatbots and agents
Synera Raises $40M Series B to Scale Agentic AI Engineering for Global Manufacturers April 14, 2026 Agentic AI platform that orchestrates the full engineering value chain across 80+ hardware engineering tools, which operates securely, on‑premise, and without disrupting existing systems, announces $40M (€35M) raise in Series B. Round led by Revaia, a leading European growth technology investor, with participation from UVC (€6M), to accelerate U.S. and international expansion. Adopted by NASA, BMW, Airbus, Volvo Trucks, and Hyundai to drive AI-ready organizational transformation, address the engineering talent shortage, and reduce costs and material usage.
Promega Expands Forensic Portfolio with Distribution Agreement for NimaGen’s IDseek® MPS Library Prep Kits April 14, 2026 Agreement adds STR, SNP, microhaplotype and mitochondrial DNA MPS kits to Promega forensic product lineup
PSV And Paladin Enter Into a Three-Year Partnership April 14, 2026 International ITAD provider Paladin will join the newly minted league champions as an Official Sponsor and Official Technology Recycling Partner through the 2029 season.
Jeito Capital leads oversubscribed $75 million Series C in Adcendo ApS to Advance its First- and Best-in-class Clinical ADC1 Pipeline in Oncology April 14, 2026 Proceeds from the financing will support the advancement of three first- and best-in-class ADC programs through upcoming key clinical milestones While oncology continues to face substantial and largely unmet needs, Jeito will leverage its expertise to accelerate Adcendo’s broad, high-potential portfolio of novel therapies and deliver transformational benefits to patients
